Tyler M Gunn,Christopher T Salerno
Tyler M Gunn
Re-evaluating ischemic tolerance and prognostic accuracy in DCD cardiac transplantation: A critical appraisal of taNRP outcomes [0.03%]
重新评估DCD心脏移植中的缺血耐受和预后准确性：对taNRP结果的批判性评价
Weikai Dong,Shan Lu,Zhikang Lv
Weikai Dong
Metabolomic Signature of RV-PA Coupling Differentiates Haemodynamic Response to Imatinib Therapy in Pulmonary Arterial Hypertension [0.03%]
伊马替尼治疗肺动脉高压血流动力学反应差异的代谢标志物研究
Lars Harbaum,Hans Klose,Jonas Lund et al.
Lars Harbaum et al.
Background: Right ventricular (RV) dysfunction is the leading cause of mortality in pulmonary arterial hypertension (PAH). Although RV metabolic remodelling in chronic pressure overload is recognised, the circulating meta...
Beyond the edge [0.03%]
绝境之外
Cristiano Amarelli
Cristiano Amarelli
In an Era of tMCS and Organ Expansion, Why Is 'The Waiting' Still the Hardest Part? [0.03%]
在tMCS和器官扩增的时代，为什么“等待”依旧是最难的部分？
Sounok Sen,Marc D Samsky
Sounok Sen
Invited Response Letter [0.03%]
受邀答复函件
Alexander R Berg,Aravind Krishnan,Elbert E Heng et al.
Alexander R Berg et al.
Impact of left ventricular assist device implantation on right ventricular-pulmonary arterial coupling assessed by high-fidelity hemodynamics [0.03%]
高保真血流动力学评估下左心室辅助装置植入对右心室-肺动脉耦合的影响
Alina Nicoara,Mary Cooter Wright,Kendall Hunter et al.
Alina Nicoara et al.
Background: Postoperative right ventricular (RV) adaptation to left ventricular assist device (LVAD) implantation remains poorly characterized. RV-pulmonary artery (PA) coupling, defined as the ratio of end-systolic to ar...
Immature neutrophils are elevated in human PGD and linked to G-CSF-driven injury in a murine model of lung ischemia-reperfusion [0.03%]
人PGD中中性粒细胞增多与小鼠肺缺血再灌注损伤模型中的G-CSF驱动损伤有关
Rachel Klein,Jonathan Braat,Ashwini Arjuna et al.
Rachel Klein et al.
Background: Primary Graft Dysfunction (PGD) is an early post-lung transplant (LTx) inflammatory condition primarily driven by lung ischemia-reperfusion injury (LIRI). Neutrophils are key mediators of LIRI, but their pheno...
Multimodal Molecular Testing for Heart Transplant Recipients - Is it actionable yet? [0.03%]
心脏移植受者的多模态分子检测手段-其临床指导意义如何？
Eileen M Hsich,Marc K Halushka
Eileen M Hsich